Including Wellness in the Pharma Model - How Drug Delivery will be a Key Enabler
In this industry keynote recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference, Justin Wright, PhD, Global Head of Innovation, Novartis, discusses how the transformat...
21 Juli 201925min
Service & Patients in Clinical Trials
In this podcast from DPharm 2018, Chip Bell shows pragmatic ways to change our culture to support service-oriented thinking that benefits patients and investigators. The patient's expectations are bei...
21 Juli 201946min
Panel: Delivering mRNA Drugs and Vaccines – Progress and Future Outlook
Moderated by Marian Gindy, PhD, Executive Director, Discovery Pharmaceutical Sciences, Merck, this panel discussion recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) confere...
20 Juli 201937min
How to Innovate like Amazon to Modernize Clinical Trials
This session was presented at the 8th annual DPharm conference in September 2018. When Amazon announced that the creation of a new healthcare company with Berkshire Hathaway and JPMorgan Chase, the m...
11 Juli 201940min
Alzheimer’s Studies: Exploring Registries to Improve Enrollment & Trial Design
Roughly, 5.7 million people in the U.S. are living with Alzheimer’s. Globally, an estimated 47 million individuals are living with dementia. There is no cure, and treatments can only relieve certain s...
25 Juni 201930min
4th Annual IO Combinations 360°: What to Expect in 8 Minutes
This 8 minute podcast summarizes what you can expect at the 4th annual IO Combinations 360° conference. This conference provides the latest data impacting immuno-oncology combinations and patient trea...
23 Maj 20198min
CAR-T Therapy: Optimization Through Engineering T-cells or Combinations
Dr Marco Ruella, Assistant Professor and Scientific Director Lymphoma Program, Division of Hematology and Oncology, Department of Medicine and Center for Cellular Immunotherapies (CCI), Perelman Schoo...
2 Maj 201920min
Combining IO Modalities In a Cost Effective, Patient Beneficial Manner
The hardest thing to figure out now is what interventions and combinations make the most sense in which patients and how to combine all these emerging modalities in a way that is cost effective, benef...
1 Maj 201940min
